GONADOTROPHIN, CHORIONIC

GONADOTROPHIN, CHORIONIC was reported 621 times

GONADOTROPHIN, CHORIONIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AICHMOPHOBIA 1 0.5000
1 HUMAN CHORIONIC GONADOTROPIN NEGATIVE 2 0.0952
2 OESOPHAGOSCOPY 1 0.0909
3 PRODUCT DISPENSED BY UNAUTHORISED PROVIDER 1 0.0909
4 EPIDURAL CATHETER PLACEMENT 1 0.0769
5 ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE 1 0.0769
6 OVARIAN HYPERSTIMULATION SYNDROME 115 0.0493
7 NOTHING BY MOUTH ORDER 1 0.0455
8 UVULOPALATOPHARYNGOPLASTY 1 0.0455
9 OVARIAN CYST TORSION 2 0.0339
10 ACQUIRED MIXED HYPERLIPIDAEMIA 1 0.0333
11 BIOCHEMICAL PREGNANCY 3 0.0278
12 OVARIAN ABSCESS 4 0.0256
13 VACCINATION SITE MASS 1 0.0244
14 MALIGNANT LYMPHOID NEOPLASM 1 0.0204
15 ABORTION EARLY 2 0.0185
16 OVARIAN HAEMORRHAGE 4 0.0169
17 OVARIAN ENLARGEMENT 6 0.0157
18 BLOOD FOLLICLE STIMULATING HORMONE ABNORMAL 1 0.0154
19 ABDOMINAL WALL DISORDER 4 0.0137
20 OVARIAN TORSION 1 0.0120
21 ANGIOKERATOMA 1 0.0118
22 MULTIPLE PREGNANCY 2 0.0112
23 UTERINE HYPERSTIMULATION 1 0.0098
24 WAIST CIRCUMFERENCE INCREASED 10 0.0096
25 PRODUCT ADMINISTRATION ISSUE 2 0.0096
26 PREGNANCY TEST NEGATIVE 1 0.0095
27 POSTPARTUM DISORDER 1 0.0093
28 SHIGELLA INFECTION 1 0.0088
29 PELVIC FLUID COLLECTION 6 0.0085
30 COPPER DEFICIENCY 1 0.0083
31 UTERINE HYPOTONUS 1 0.0079
32 TESTICULAR FAILURE 1 0.0073
33 THORACOTOMY 1 0.0070
34 FORCED EXPIRATORY VOLUME ABNORMAL 1 0.0069
35 PERITONEAL HAEMATOMA 1 0.0067
36 SMOOTH MUSCLE ANTIBODY POSITIVE 1 0.0053
37 VACCINATION SITE ERYTHEMA 1 0.0046
38 TUBO-OVARIAN ABSCESS 1 0.0041
39 NIPPLE SWELLING 1 0.0040
40 OVARIAN CYST RUPTURED 5 0.0039
41 PRODUCT IMPURITY 1 0.0036
42 OESOPHAGEAL OEDEMA 1 0.0035
43 HAEMORRHAGIC OVARIAN CYST 2 0.0035
44 OESTRADIOL INCREASED 1 0.0033
45 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
46 ADNEXAL TORSION 1 0.0032
47 ECHOLALIA 1 0.0031
48 SERUM FERRITIN ABNORMAL 1 0.0031
49 COLORECTAL ADENOMA 1 0.0031
50 ASTHMA EXERCISE INDUCED 1 0.0029
51 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
52 SALIVARY GLAND CALCULUS 1 0.0027
53 CARDITIS 1 0.0024
54 THREATENED LABOUR 1 0.0023
55 BULIMIA NERVOSA 1 0.0023
56 PELVIC HAEMATOMA 1 0.0023
57 PREGNANCY TEST FALSE POSITIVE 1 0.0021
58 SKIN INDENTATION 1 0.0021
59 WOLFF-PARKINSON-WHITE SYNDROME 1 0.0021
60 THROMBOPHLEBITIS 7 0.0020
61 WRONG PATIENT 1 0.0020
62 HYPERMETABOLISM 1 0.0019
63 OVARIAN FAILURE 1 0.0019
64 MATERNAL EXPOSURE BEFORE PREGNANCY 12 0.0018
65 BLOOD OESTROGEN INCREASED 1 0.0017
66 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
67 DERMATILLOMANIA 1 0.0017
68 DIAPHRAGMATIC HERNIA 1 0.0016
69 CORTISOL INCREASED 1 0.0016
70 NEUROPATHIC ARTHROPATHY 1 0.0015
71 HALLUCINATION, TACTILE 1 0.0015
72 MAMMOGRAM ABNORMAL 1 0.0015
73 HEAD AND NECK CANCER 1 0.0015
74 CERVICAL RADICULOPATHY 1 0.0014
75 MICROALBUMINURIA 1 0.0013
76 MYASTHENIC SYNDROME 1 0.0013
77 RUPTURED ECTOPIC PREGNANCY 1 0.0013
78 BREAST FEEDING 1 0.0013
79 POLYPECTOMY 1 0.0013
80 TUMOUR EXCISION 1 0.0012
81 VULVOVAGINAL ERYTHEMA 1 0.0012
82 TWIN PREGNANCY 1 0.0012
83 EOSINOPHILIC PNEUMONIA ACUTE 1 0.0012
84 BREAST DISCHARGE 2 0.0011
85 PERIPHERAL NERVE INJURY 1 0.0011
86 FOLLICULAR LYMPHOMA 1 0.0011
87 VULVOVAGINAL DISCOMFORT 5 0.0011
88 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
89 ESSENTIAL HYPERTENSION 2 0.0011
90 ADVERSE FOOD REACTION 1 0.0011
91 WRIST SURGERY 1 0.0011
92 OVARIAN DISORDER 1 0.0011
93 PELVIC DISCOMFORT 1 0.0011
94 HEPATIC CONGESTION 1 0.0011
95 COARCTATION OF THE AORTA 1 0.0010
96 TESTICULAR DISORDER 1 0.0010
97 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
98 BINGE EATING 1 0.0009
99 BRONCHIAL HYPERREACTIVITY 1 0.0008
100 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
101 VICTIM OF CRIME 1 0.0008
102 INTERVERTEBRAL DISC OPERATION 1 0.0008
103 ABDOMINAL TENDERNESS 4 0.0008
104 ENDOCRINE DISORDER 1 0.0008
105 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
106 ENCEPHALITIS AUTOIMMUNE 1 0.0008
107 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
108 THERAPEUTIC PROCEDURE 1 0.0007
109 MAST CELL ACTIVATION SYNDROME 1 0.0007
110 FAT TISSUE INCREASED 1 0.0007
111 PRECANCEROUS SKIN LESION 1 0.0007
112 INFERTILITY 1 0.0007
113 HAEMOGLOBIN INCREASED 3 0.0007
114 RUBBER SENSITIVITY 1 0.0007
115 DAYDREAMING 1 0.0006
116 ASCITES 19 0.0006
117 INHIBITORY DRUG INTERACTION 1 0.0006
118 SHOULDER FRACTURE 1 0.0006
119 METABOLIC SYNDROME 1 0.0006
120 ARTHROPOD STING 1 0.0006
121 TONSILLECTOMY 1 0.0006
122 SLEEP TALKING 1 0.0006
123 RETINITIS 1 0.0006
124 SPONDYLOLISTHESIS 1 0.0006
125 THYROIDECTOMY 1 0.0006
126 HANGOVER 2 0.0006
127 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
128 OBSESSIVE THOUGHTS 1 0.0006
129 BODY TEMPERATURE ABNORMAL 1 0.0005
130 VITRITIS 1 0.0005
131 HYPERTRICHOSIS 1 0.0005
132 BLADDER SPASM 1 0.0005
133 NARCOLEPSY 1 0.0005
134 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
135 LIBIDO INCREASED 1 0.0005
136 NIPPLE PAIN 1 0.0005
137 CHEST INJURY 1 0.0005
138 BLOOD TESTOSTERONE INCREASED 1 0.0005
139 SOMNAMBULISM 3 0.0005
140 ABORTION SPONTANEOUS 18 0.0004
141 FEAR OF DEATH 1 0.0004
142 HAEMATOCRIT INCREASED 1 0.0004
143 BLOOD TESTOSTERONE DECREASED 3 0.0004
144 TRANSPLANT 1 0.0004
145 WRONG DOSE 1 0.0004
146 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
147 DENTAL OPERATION 1 0.0004
148 INFLAMMATORY MARKER INCREASED 2 0.0004
149 INJECTION SITE ABSCESS 1 0.0004
150 STEM CELL TRANSPLANT 1 0.0004
151 OSTEITIS 1 0.0004
152 DERMATOMYOSITIS 1 0.0004
153 ENDODONTIC PROCEDURE 1 0.0004
154 ACTINIC KERATOSIS 1 0.0004
155 ADVERSE REACTION 5 0.0004
156 OVERWEIGHT 2 0.0004
157 BREAST SWELLING 1 0.0004
158 ABDOMINAL RIGIDITY 1 0.0004
159 RED BLOOD CELL COUNT INCREASED 1 0.0004
160 PLEURITIC PAIN 1 0.0004
161 INTRACRANIAL PRESSURE INCREASED 2 0.0004
162 ABDOMINAL PAIN LOWER 9 0.0004
163 ERECTILE DYSFUNCTION 9 0.0004
164 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
165 HAEMOTHORAX 1 0.0003
166 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
167 ABORTION 1 0.0003
168 NECK INJURY 1 0.0003
169 ABDOMINAL DISTENSION 35 0.0003
170 SYMPTOM RECURRENCE 2 0.0003
171 CRANIOCEREBRAL INJURY 1 0.0003
172 EMERGENCY CARE 1 0.0003
173 ECTOPIC PREGNANCY 1 0.0003
174 BILE DUCT STONE 1 0.0003
175 ORTHOPNOEA 1 0.0003
176 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
177 PHARYNGEAL SWELLING 3 0.0003
178 INCONTINENCE 3 0.0003
179 BIPOLAR DISORDER 3 0.0003
180 PELVIC PAIN 5 0.0003
181 HYPOMANIA 1 0.0003
182 BREAST TENDERNESS 2 0.0003
183 AUTOIMMUNE THYROIDITIS 1 0.0003
184 SNORING 1 0.0003
185 FOOD ALLERGY 2 0.0003
186 PANIC DISORDER 1 0.0003
187 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
188 SURGERY 15 0.0003
189 VENOUS THROMBOSIS 1 0.0003
190 AFFECTIVE DISORDER 2 0.0003
191 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
192 PATENT DUCTUS ARTERIOSUS 1 0.0003
193 INTRACRANIAL ANEURYSM 1 0.0002
194 ENURESIS 1 0.0002
195 HOMICIDAL IDEATION 1 0.0002
196 TRIGGER FINGER 1 0.0002
197 GENERALISED OEDEMA 3 0.0002
198 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
199 CARDIOVASCULAR DISORDER 6 0.0002
200 UTERINE HAEMORRHAGE 1 0.0002
201 SHOULDER OPERATION 1 0.0002
202 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
203 GROIN PAIN 2 0.0002
204 HEAVY MENSTRUAL BLEEDING 2 0.0002
205 SUSPECTED OFF LABEL USE 1 0.0002
206 EYE OPERATION 1 0.0002
207 LOCALISED OEDEMA 1 0.0002
208 APPENDICITIS 2 0.0002
209 LEUKAEMIA 2 0.0002
210 ENDOMETRIOSIS 1 0.0002
211 VITAMIN D DEFICIENCY 2 0.0002
212 HORMONE LEVEL ABNORMAL 1 0.0002
213 BREATH SOUNDS ABNORMAL 1 0.0002
214 DIABETIC NEUROPATHY 1 0.0002
215 INABILITY TO AFFORD MEDICATION 2 0.0002
216 APPLICATION SITE SWELLING 1 0.0002
217 OVARIAN CYST 2 0.0002
218 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
219 DRUG TOLERANCE 1 0.0002
220 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
221 FOETAL DEATH 1 0.0002
222 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
223 CATATONIA 1 0.0002
224 PREMATURE DELIVERY 3 0.0002
225 COMPRESSION FRACTURE 1 0.0002
226 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
227 BRUXISM 1 0.0002
228 HIP SURGERY 1 0.0002
229 NORMAL NEWBORN 1 0.0002
230 AUTISM SPECTRUM DISORDER 1 0.0002
231 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
232 NERVE INJURY 2 0.0002
233 HEART RATE ABNORMAL 1 0.0002
234 INTERMENSTRUAL BLEEDING 1 0.0002
235 CHOLECYSTITIS ACUTE 1 0.0002
236 INTENTIONAL DOSE OMISSION 5 0.0002
237 VENTRICULAR SEPTAL DEFECT 1 0.0002
238 PRODUCT LABEL CONFUSION 1 0.0002
239 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
240 TYPE 1 DIABETES MELLITUS 1 0.0002
241 INJECTION SITE RASH 5 0.0002
242 SPINAL OPERATION 2 0.0002
243 PRE-EXISTING CONDITION IMPROVED 1 0.0002
244 THERAPEUTIC RESPONSE CHANGED 1 0.0002
245 PROCTALGIA 1 0.0002
246 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
247 PRODUCT PREPARATION ISSUE 1 0.0002
248 PRODUCT FORMULATION ISSUE 1 0.0002
249 DYSMENORRHOEA 2 0.0002
250 SPINAL FRACTURE 3 0.0001
251 POST-TRAUMATIC STRESS DISORDER 1 0.0001
252 WRONG PRODUCT ADMINISTERED 1 0.0001
253 RESPIRATION ABNORMAL 1 0.0001
254 LYMPHOEDEMA 1 0.0001
255 PROCEDURAL PAIN 4 0.0001
256 APHONIA 2 0.0001
257 CARPAL TUNNEL SYNDROME 2 0.0001
258 FEAR OF INJECTION 1 0.0001
259 IRRITABLE BOWEL SYNDROME 3 0.0001
260 IMPAIRED QUALITY OF LIFE 2 0.0001
261 PANIC REACTION 1 0.0001
262 ORAL DISORDER 1 0.0001
263 BLINDNESS TRANSIENT 1 0.0001
264 CEREBRAL DISORDER 1 0.0001
265 FEELING DRUNK 1 0.0001
266 PREMATURE BABY 4 0.0001
267 LIPASE INCREASED 1 0.0001
268 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
269 CONGENITAL ANOMALY 1 0.0001
270 BRAIN FOG 2 0.0001
271 FURUNCLE 1 0.0001
272 RHINITIS 1 0.0001
273 FIBROMYALGIA 3 0.0001
274 DECUBITUS ULCER 1 0.0001
275 ASPHYXIA 1 0.0001
276 EOSINOPHIL COUNT INCREASED 1 0.0001
277 ATRIAL SEPTAL DEFECT 1 0.0001
278 VITAMIN D DECREASED 1 0.0001
279 PRODUCT COMMUNICATION ISSUE 1 0.0001
280 LUNG INFILTRATION 1 0.0001
281 MOOD ALTERED 3 0.0001
282 UNDERDOSE 8 0.0001
283 BRAIN NEOPLASM 1 0.0001
284 DYSURIA 4 0.0001
285 OVARIAN CANCER 1 0.0001
286 NERVE COMPRESSION 1 0.0001
287 HEPATIC STEATOSIS 2 0.0001
288 FOOT FRACTURE 2 0.0001
289 PRODUCT PACKAGING ISSUE 1 0.0001
290 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
291 NEEDLE ISSUE 3 0.0001
292 HEPATOMEGALY 1 0.0001
293 VITREOUS FLOATERS 1 0.0001
294 HOSPICE CARE 1 0.0001
295 LIGAMENT SPRAIN 1 0.0001
296 PRESCRIBED UNDERDOSE 2 0.0001
297 PREGNANCY 2 0.0001
298 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
299 EAR DISCOMFORT 1 0.0001
300 THERAPY CESSATION 5 0.0001
301 PRODUCT PREPARATION ERROR 2 0.0001
302 VENTRICULAR EXTRASYSTOLES 1 0.0001
303 KNEE ARTHROPLASTY 2 0.0001
304 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
305 OSTEOARTHRITIS 4 0.0001
306 BREAST PAIN 1 0.0001
307 VAGINAL HAEMORRHAGE 4 0.0001
308 BACK INJURY 1 0.0001
309 GASTROINTESTINAL PAIN 1 0.0001
310 FOOT DEFORMITY 1 0.0001
311 VENTRICULAR FIBRILLATION 1 0.0001
312 NEOPLASM MALIGNANT 6 0.0001
313 INJECTION SITE PRURITUS 6 0.0001
314 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
315 INJECTION SITE ERYTHEMA 11 0.0001
316 MITRAL VALVE INCOMPETENCE 1 0.0001
317 DERMATITIS CONTACT 1 0.0001
318 CHOLECYSTECTOMY 1 0.0001
319 SEXUAL DYSFUNCTION 1 0.0001
320 CHOLECYSTITIS 1 0.0001
321 ACCIDENT 1 0.0001
322 HYPERLIPIDAEMIA 1 0.0001
323 NOCTURIA 1 0.0001
324 PRESYNCOPE 2 0.0001
325 PLEURAL EFFUSION 5 0.0001
326 NO THERAPEUTIC RESPONSE 1 0.0001
327 INJECTION SITE URTICARIA 2 0.0001
328 SMALL INTESTINAL OBSTRUCTION 1 0.0001
329 TENDON RUPTURE 1 0.0001
330 EXPOSURE DURING PREGNANCY 5 0.0001
331 TOOTH EXTRACTION 1 0.0001
332 INJECTION SITE DISCOLOURATION 1 0.0001
333 MUSCLE ATROPHY 1 0.0001
334 ABDOMINAL DISCOMFORT 13 0.0001
335 HIATUS HERNIA 1 0.0001
336 INJECTION SITE INDURATION 1 0.0001
337 ANKYLOSING SPONDYLITIS 1 0.0001
338 SARS-COV-2 TEST POSITIVE 1 0.0001
339 INJECTION SITE BRUISING 6 0.0001
340 MENSTRUATION IRREGULAR 2 0.0001
341 PRODUCT TASTE ABNORMAL 1 0.0001
342 UVEITIS 1 0.0001
343 LIMB INJURY 2 0.0001
344 IMPAIRED GASTRIC EMPTYING 1 0.0001
345 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
346 INJECTION SITE REACTION 5 0.0001
347 ABNORMAL DREAMS 2 0.0001
348 DRUG ABUSE 6 0.0001
349 HUNGER 1 0.0001
350 MASS 1 0.0001
351 BRONCHOSPASM 1 0.0001
352 HYPERSOMNIA 2 0.0001
353 LETHARGY 4 0.0001
354 INJECTION SITE HAEMATOMA 1 0.0001
355 GASTROENTERITIS 1 0.0001
356 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
357 PULMONARY MASS 1 0.0001
358 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
359 IRRITABILITY 4 0.0001
360 DISCOMFORT 4 0.0001
361 SUICIDAL IDEATION 6 0.0001
362 DRUG DISPENSING ERROR 1 0.0001
363 NEPHROLITHIASIS 3 0.0001
364 HIP ARTHROPLASTY 1 0.0001
365 PHARYNGEAL OEDEMA 1 0.0001
366 EMOTIONAL DISORDER 2 0.0001
367 TENDONITIS 1 0.0001
368 ABDOMINAL PAIN 15 0.0001
369 BLOOD CHOLESTEROL INCREASED 3 0.0001
370 ACUTE MYELOID LEUKAEMIA 1 0.0001
371 MENINGIOMA 1 0.0001
372 HEAD INJURY 2 0.0001
373 DISEASE RECURRENCE 3 0.0001
374 PNEUMOTHORAX 1 0.0001
375 MIGRAINE 6 0.0001
376 OBESITY 1 0.0001
377 SCIATICA 1 0.0001
378 CONTUSION 6 0.0001
379 VOMITING 29 0.0001
380 FUNGAL INFECTION 2 0.0001
381 URINARY RETENTION 2 0.0001
382 NAUSEA 47 0.0001
383 FACE OEDEMA 1 0.0001
384 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
385 FLUID RETENTION 3 0.0001
386 ILLNESS 6 0.0001
387 MUSCULOSKELETAL DISCOMFORT 1 0.0001
388 NIGHTMARE 2 0.0001
389 DEVICE USE ISSUE 1 0.0001
390 NEUROTOXICITY 1 0.0001
391 AMENORRHOEA 1 0.0001
392 PANCREATITIS 3 0.0001
393 DRUG ERUPTION 1 0.0001
394 TACHYCARDIA 5 0.0001
395 GALLBLADDER DISORDER 1 0.0001
396 THERAPY INTERRUPTED 4 0.0001
397 HEADACHE 35 0.0001
398 DISTURBANCE IN ATTENTION 3 0.0001
399 LEUKOCYTOSIS 1 0.0001
400 RESTLESS LEGS SYNDROME 1 0.0001
401 BONE DISORDER 1 0.0001
402 PANIC ATTACK 2 0.0001
403 LOSS OF CONSCIOUSNESS 7 0.0001
404 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
405 PRODUCT DOSE OMISSION ISSUE 16 0.0001
406 INJECTION SITE MASS 2 0.0001
407 THINKING ABNORMAL 1 0.0001
408 WEIGHT INCREASED 12 0.0001
409 SWELLING 5 0.0001
410 HEPATIC CIRRHOSIS 1 0.0001
411 NEUROPATHY PERIPHERAL 5 0.0001
412 SLEEP APNOEA SYNDROME 1 0.0001
413 INJECTION SITE SWELLING 4 0.0001
414 POST PROCEDURAL COMPLICATION 1 0.0001
415 SEROTONIN SYNDROME 1 0.0001
416 HYPERTENSION 11 0.0001
417 PRESCRIBED OVERDOSE 1 0.0001
418 EAR PAIN 1 0.0001
419 SKIN FISSURES 1 0.0001
420 MENORRHAGIA 1 0.0001
421 DISABILITY 1 0.0001
422 CONSTIPATION 11 0.0001
423 HAEMATOCRIT DECREASED 1 0.0001
424 UPPER LIMB FRACTURE 1 0.0001
425 PRODUCT PHYSICAL ISSUE 1 0.0000
426 FEEDING DISORDER 1 0.0000
427 DYSKINESIA 2 0.0000
428 OSTEOPOROSIS 2 0.0000
429 RIB FRACTURE 1 0.0000
430 JOINT INJURY 1 0.0000
431 LIVER FUNCTION TEST INCREASED 1 0.0000
432 SWELLING FACE 3 0.0000
433 MENTAL DISORDER 2 0.0000
434 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
435 PRODUCT STORAGE ERROR 4 0.0000
436 HOSPITALISATION 7 0.0000
437 ANGIOEDEMA 2 0.0000
438 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
439 TRANSAMINASES INCREASED 1 0.0000
440 RASH MACULO-PAPULAR 1 0.0000
441 THERAPY NON-RESPONDER 2 0.0000
442 ASTHMA 5 0.0000
443 APPLICATION SITE PRURITUS 1 0.0000
444 DEPRESSION 10 0.0000
445 PRODUCT AVAILABILITY ISSUE 1 0.0000
446 RASH 19 0.0000
447 ADVERSE EVENT 4 0.0000
448 SEIZURE 5 0.0000
449 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
450 INJURY 3 0.0000
451 PRODUCT USE ISSUE 8 0.0000
452 DRUG INEFFECTIVE 56 0.0000
453 DYSPNOEA 24 0.0000
454 PULMONARY EMBOLISM 4 0.0000
455 PRODUCT PRESCRIBING ERROR 1 0.0000
456 DRUG INTOLERANCE 4 0.0000
457 LOCALISED INFECTION 1 0.0000
458 NEURALGIA 1 0.0000
459 OFF LABEL USE 36 0.0000
460 AGITATION 3 0.0000
461 BRONCHITIS 3 0.0000
462 HEART RATE INCREASED 4 0.0000
463 DRY EYE 2 0.0000
464 SYNCOPE 4 0.0000
465 COVID-19 7 0.0000
466 HOT FLUSH 3 0.0000
467 SEDATION 1 0.0000
468 APPLICATION SITE ERYTHEMA 1 0.0000
469 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
470 GASTRITIS 1 0.0000
471 DEPRESSED MOOD 2 0.0000
472 PRODUCT QUALITY ISSUE 5 0.0000
473 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
474 RESPIRATORY ARREST 1 0.0000
475 RESPIRATORY DISTRESS 1 0.0000
476 INJECTION SITE PAIN 11 0.0000
477 BLISTER 2 0.0000
478 EYE PAIN 2 0.0000
479 TARDIVE DYSKINESIA 1 0.0000
480 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
481 FLATULENCE 2 0.0000
482 LIVER FUNCTION TEST ABNORMAL 1 0.0000
483 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
484 NASAL CONGESTION 2 0.0000
485 PSYCHOTIC DISORDER 1 0.0000
486 RENAL INJURY 1 0.0000
487 CATARACT 2 0.0000
488 RESPIRATORY DISORDER 1 0.0000
489 BLOOD POTASSIUM DECREASED 1 0.0000
490 APHASIA 1 0.0000
491 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
492 MUSCLE SPASMS 6 0.0000
493 GYNAECOMASTIA 1 0.0000
494 FATIGUE 25 0.0000
495 BONE DENSITY DECREASED 1 0.0000
496 ANXIETY 9 0.0000
497 MOOD SWINGS 1 0.0000
498 NIGHT SWEATS 1 0.0000
499 DEVICE DIFFICULT TO USE 2 0.0000
500 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
501 EXPIRED PRODUCT ADMINISTERED 1 0.0000
502 LIP SWELLING 1 0.0000
503 DEHYDRATION 4 0.0000
504 GAIT INABILITY 1 0.0000
505 URTICARIA 5 0.0000
506 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
507 HEPATIC ENZYME INCREASED 2 0.0000
508 CHEST DISCOMFORT 3 0.0000
509 FEELING ABNORMAL 7 0.0000
510 NEOPLASM PROGRESSION 1 0.0000
511 HAEMORRHAGE 3 0.0000
512 BURNING SENSATION 2 0.0000
513 SLEEP DISORDER 2 0.0000
514 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
515 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
516 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
517 MOBILITY DECREASED 2 0.0000
518 CRYING 1 0.0000
519 EYE SWELLING 1 0.0000
520 DYSARTHRIA 1 0.0000
521 INTESTINAL OBSTRUCTION 1 0.0000
522 UNEVALUABLE EVENT 2 0.0000
523 ACNE 2 0.0000
524 CHRONIC KIDNEY DISEASE 2 0.0000
525 INSOMNIA 7 0.0000
526 DIABETES MELLITUS 2 0.0000
527 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
528 DIZZINESS 13 0.0000
529 PAIN 16 0.0000
530 PALPITATIONS 3 0.0000
531 DRUG DOSE OMISSION BY DEVICE 2 0.0000
532 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
533 JOINT SWELLING 3 0.0000
534 SOMNOLENCE 5 0.0000
535 EXTRA DOSE ADMINISTERED 1 0.0000
536 DRY MOUTH 2 0.0000
537 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
538 BLINDNESS 1 0.0000
539 RHABDOMYOLYSIS 1 0.0000
540 WITHDRAWAL SYNDROME 1 0.0000
541 HYPOACUSIS 1 0.0000
542 BALANCE DISORDER 2 0.0000
543 DEVICE LEAKAGE 1 0.0000
544 MUSCULOSKELETAL STIFFNESS 2 0.0000
545 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
546 THROAT IRRITATION 1 0.0000
547 VISION BLURRED 3 0.0000
548 NASOPHARYNGITIS 4 0.0000
549 DECREASED APPETITE 5 0.0000
550 WEIGHT DECREASED 6 0.0000
551 BREAST CANCER 2 0.0000
552 COGNITIVE DISORDER 1 0.0000
553 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
554 ARRHYTHMIA 1 0.0000
555 DYSPHAGIA 2 0.0000
556 FALL 7 0.0000
557 COLORECTAL CANCER 1 0.0000
558 RASH ERYTHEMATOUS 1 0.0000
559 MULTIPLE SCLEROSIS 1 0.0000
560 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
561 INFECTION 3 0.0000
562 INTERSTITIAL LUNG DISEASE 1 0.0000
563 ATRIAL FIBRILLATION 2 0.0000
564 ALOPECIA 4 0.0000
565 DIARRHOEA 13 0.0000
566 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
567 SINUSITIS 2 0.0000
568 PERIPHERAL SWELLING 3 0.0000
569 ABDOMINAL PAIN UPPER 4 0.0000
570 INFLAMMATION 1 0.0000
571 NERVOUSNESS 1 0.0000
572 DERMATITIS ATOPIC 1 0.0000
573 DRUG EFFECT DECREASED 1 0.0000
574 OEDEMA 1 0.0000
575 TREATMENT NONCOMPLIANCE 1 0.0000
576 PRURITUS 7 0.0000
577 ANAPHYLACTIC REACTION 1 0.0000
578 TREMOR 3 0.0000
579 INFLUENZA 2 0.0000
580 SEPSIS 2 0.0000
581 COUGH 5 0.0000
582 CEREBROVASCULAR ACCIDENT 3 0.0000
583 MUSCULAR WEAKNESS 2 0.0000
584 CONVULSION 1 0.0000
585 HERPES ZOSTER 1 0.0000
586 PRODUCT SUBSTITUTION ISSUE 1 0.0000
587 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
588 DYSPHONIA 1 0.0000
589 CHILLS 2 0.0000
590 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
591 THERAPEUTIC RESPONSE DECREASED 1 0.0000
592 SUICIDE ATTEMPT 1 0.0000
593 CONDITION AGGRAVATED 5 0.0000
594 FEELING HOT 1 0.0000
595 INTENTIONAL OVERDOSE 1 0.0000
596 HYPERHIDROSIS 2 0.0000
597 RHINORRHOEA 1 0.0000
598 DEEP VEIN THROMBOSIS 1 0.0000
599 BLOOD CREATININE INCREASED 1 0.0000
600 BLOOD PRESSURE DECREASED 1 0.0000
601 DRY SKIN 2 0.0000
602 MEMORY IMPAIRMENT 2 0.0000
603 SKIN BURNING SENSATION 1 0.0000
604 MALAISE 6 0.0000
605 HALLUCINATION 1 0.0000
606 INCORRECT DOSE ADMINISTERED 3 0.0000
607 INJECTION SITE HAEMORRHAGE 1 0.0000
608 CARDIAC FAILURE CONGESTIVE 1 0.0000
609 DRUG DEPENDENCE 2 0.0000
610 THROMBOSIS 1 0.0000
611 INFLUENZA LIKE ILLNESS 1 0.0000
612 CARDIAC ARREST 1 0.0000
613 TREATMENT FAILURE 1 0.0000
614 SKIN EXFOLIATION 1 0.0000
615 MYALGIA 2 0.0000
616 PYREXIA 4 0.0000
617 ADVERSE DRUG REACTION 1 0.0000
618 NO ADVERSE EVENT 2 0.0000
619 OROPHARYNGEAL PAIN 1 0.0000
620 HYPERSENSITIVITY 2 0.0000
621 DYSPEPSIA 1 0.0000
622 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
623 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
624 PNEUMONIA 3 0.0000
625 RHEUMATOID ARTHRITIS 1 0.0000
626 BACK PAIN 2 0.0000
627 EMOTIONAL DISTRESS 1 0.0000
628 VISUAL IMPAIRMENT 1 0.0000
629 ASTHENIA 3 0.0000
630 PSORIASIS 1 0.0000
631 RENAL FAILURE 1 0.0000
632 PAIN IN EXTREMITY 2 0.0000
633 HYPOAESTHESIA 1 0.0000
634 BLOOD PRESSURE INCREASED 1 0.0000
635 ACUTE KIDNEY INJURY 1 0.0000
636 CONFUSIONAL STATE 1 0.0000
637 MYOCARDIAL INFARCTION 1 0.0000
638 CHEST PAIN 1 0.0000
639 ANAEMIA 1 0.0000
640 GAIT DISTURBANCE 1 0.0000
641 HYPOTENSION 1 0.0000
642 ERYTHEMA 1 0.0000
643 OVERDOSE 1 0.0000
644 ARTHRALGIA 1 0.0000
645 DEATH 2 0.0000